Federal award
HENRY SCHEIN, INC.
N6264521P2043
Contract
Obligated and Ceiling
- Obligated (net)
- $403,553.72
- Ceiling (potential value, not spending)
- $403,553.72
- Current value
- $403,553.72
- Gross positive obligations
- $416,581.54
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- HENRY SCHEIN, INC. · D6MTSKS115L9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- HENRY SCHEIN, INC. · D6MTSKS115L9
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6264521P2043
- Award type code
- B
- Actions
- 9 · Sep 27, 2021 to Dec 4, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 4, 2023 | FY2024 | P00008 | C | −$13,027.82 | — |
| Jul 5, 2022 | FY2022 | P00007 | M | $0.00 | — |
| Apr 27, 2022 | FY2022 | P00006 | B | $12,056.29 | — |
| Mar 18, 2022 | FY2022 | P00005 | C | $275,834.47 | — |
| Dec 22, 2021 | FY2022 | P00004 | M | $96,518.09 | — |
| Dec 3, 2021 | FY2022 | P00003 | M | $0.00 | — |
| Nov 15, 2021 | FY2022 | P00002 | M | $0.00 | — |
| Oct 25, 2021 | FY2022 | P00001 | C | $32,172.69 | — |
| Sep 27, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.